Jordan Park Group LLC Oncocyte Corp Transaction History

Jordan Park Group LLC

  • $1.33 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Dec 28, 2021
BUY
$2.39 - $6.5 $40,630 - $110,500
17,000 New
17,000 $88,000

Others Institutions Holding OCX

# of Institutions
3
Shares Held
411K
Call Options Held
0
Put Options Held
0
View Full List

About Oncocyte Corp

OCX Quotes by TradingView
  • Ticker OCX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,609,000
  • Market Cap $294M
  • Description
  • OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....
More about OCX
Track This Portfolio

Track Jordan Park Group LLC Portfolio

Follow Jordan Park Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jordan Park Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jordan Park Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email